Novabay Pharmaceuticals, Inc. approved to elect Mijia (Bob) Wu Class I directors nominated by the Company's Board of Directors to hold office for a term of three (3) years or until their respective successors are elected and qualified.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.08 USD | +1.52% | +10.34% | -60.78% |
Mar. 26 | Transcript : NovaBay Pharmaceuticals, Inc., Q4 2023 Earnings Call, Mar 26, 2024 | |
Mar. 26 | NovaBay Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
EPS Revisions
- Stock Market
- Equities
- NBY Stock
- News NovaBay Pharmaceuticals
- Novabay Pharmaceuticals, Inc. Approves to Elect Mijia Wu as Director